Skip to main content

Featured

SB holds youth leadership forum

The annual review of the Security Bureau Youth Uniformed Group Leaders Forum was held today, with Acting Chief Executive Chan Kwok-ki giving a speech.   Mr Chan reported that the forum had organised nearly 20 activities over the past year, including courses and training camps run by the bureau’s disciplined services and auxiliary services, and seminars on the country’s Constitution, the Basic Law and the Hong Kong National Security Law. It also organised visits to Beijing, Shaanxi and Greater Bay Area cities, allowing participants to learn more about national affairs and broaden their horizons.   He said he was pleased to note that the bureau plans to strengthen co-operation between the Leaders Forum and Shenzhen University to enhance exchanges between youths in Hong Kong and Shenzhen, deepening their understanding of the development opportunities in the bay area and increasing Hong Kong’s integration into national development.   Noting that members had undergone significant grow
Read more

Vaccine packaging issue probed

(To watch the full media session with sign language interpretation, click here.)   An investigation by BioNTech has revealed that packaging defects in its COVID-19 vaccine vials were caused by the crimping process and ultra-low storage temperature but did not affect the jabs' safety.   Director of Health Dr Constance Chan told a media session this afternoon that the Department of Health received a written notification from BioNTech today on its investigation into the packaging issue.   Dr Chan said: “Upon further investigation, samples (of the BioNTech vaccine vials with packaging defects) detected in Hong Kong were sent back to Germany for an investigation. They have done numerous tests and experiments on the vials concerned. They have also done tests in another fill and finish plant operated by Baxter.   “In the process, they found out that in the vials packed at the site which provided batches (numbered) 210102 and 210104, there were issues related to the so-called crimping process. Crimping is the process by which pressure is applied to the aluminium ring which affixes to the rubber stopper at the top of the vial.   “We received a report that the (defect in question) is related to the process of crimping and at the same time the condition of the ultra-low temperature of minus 70 degrees Celsius. So that is why BioNTech has now decided to send the new vials from Baxter which have undergone repeated experiments and investigations, and that would exclude further occurrence of such an event.”
http://dlvr.it/RwqH65

Popular Posts